Development of a New Antileishmanial Aziridine-2,3-Dicarboxylate-Based Inhibitor with High Selectivity for Parasite Cysteine Proteases.
about
Development of a New Antileishmanial Aziridine-2,3-Dicarboxylate-Based Inhibitor with High Selectivity for Parasite Cysteine Proteases.
description
2015 nî lūn-bûn
@nan
2015 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Development of a New Antileish ...... r Parasite Cysteine Proteases.
@ast
Development of a New Antileish ...... r Parasite Cysteine Proteases.
@en
Development of a New Antileish ...... r Parasite Cysteine Proteases.
@nl
type
label
Development of a New Antileish ...... r Parasite Cysteine Proteases.
@ast
Development of a New Antileish ...... r Parasite Cysteine Proteases.
@en
Development of a New Antileish ...... r Parasite Cysteine Proteases.
@nl
prefLabel
Development of a New Antileish ...... r Parasite Cysteine Proteases.
@ast
Development of a New Antileish ...... r Parasite Cysteine Proteases.
@en
Development of a New Antileish ...... r Parasite Cysteine Proteases.
@nl
P2093
P2860
P50
P356
P1476
Development of a New Antileish ...... r Parasite Cysteine Proteases.
@en
P2093
Alicia Ponte-Sucre
Benjamin Frank
Caroline Schad
Felix Mattern
Heidrun Moll
Uta Schurigt
Uwe Dietzel
P2860
P304
P356
10.1128/AAC.00426-15
P407
P577
2015-11-23T00:00:00Z